Rigel Pharmaceuticals Stock Options
| RIGL Stock | USD 20.86 0.80 3.99% |
Rigel Pharmaceuticals' latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 1.3 with a put-to-call open interest ratio of 0.19 over 34 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on September 19th 2025.
Open Interest Against September 19th 2025 Option Contracts
2025-09-19
The chart above shows Rigel Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Rigel Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Rigel Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Rigel Pharmaceuticals
Analyzing Rigel Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Rigel Pharmaceuticals regardless of its overall volatility. This is especially true when Rigel Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Rigel Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Rigel Pharmaceuticals' stock while costing only a fraction of its price.
Rigel Pharmaceuticals In The Money Call Balance
When Rigel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Rigel Pharmaceuticals stock is said to be in the money. When it comes to buying Rigel Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Rigel Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Rigel Current Options Market Mood
Rigel Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Rigel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Rigel Pharmaceuticals' options investors are not very successful. Rigel Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Rigel contract
Base on the Rule 16, the options market is currently suggesting that Rigel Pharmaceuticals will have an average daily up or down price movement of about 0.0813% per day over the life of the 2025-09-19 option contract. With Rigel Pharmaceuticals trading at USD 20.86, that is roughly USD 0.0169. If you think that the market is fully incorporating Rigel Pharmaceuticals' daily price movement you should consider buying Rigel Pharmaceuticals options at the current volatility level of 1.3%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Rigel Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Rigel calls. Remember, the seller must deliver Rigel Pharmaceuticals stock to the call owner when a call is exercised.
Rigel Pharmaceuticals Option Chain
When Rigel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Rigel Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Rigel Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Rigel. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Rigel. It also shows strike prices and maturity days for a Rigel Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | RIGL250919C00035000 | 37 | 35.0 | 0.0 - 4.8 | 0.15 | Out |
Call | RIGL250919C00030000 | 56 | 30.0 | 0.1 - 1.8 | 0.65 | Out |
Call | RIGL250919C00025000 | 76 | 25.0 | 0.0 - 4.8 | 0.85 | Out |
Call | RIGL250919C00024000 | 33 | 24.0 | 0.0 - 4.8 | 2.06 | Out |
Call | RIGL250919C00023000 | 93 | 23.0 | 0.6 - 1.45 | 1.02 | Out |
Call | RIGL250919C00022000 | 82 | 22.0 | 0.0 - 4.1 | 1.3 | Out |
Call | RIGL250919C00021000 | 21 | 21.0 | 0.0 - 4.1 | 1.65 | Out |
Call | RIGL250919C00020000 | 30 | 20.0 | 1.5 - 4.1 | 2.17 | Out |
Call | RIGL250919C00019000 | 19 | 19.0 | 1.55 - 4.9 | 2.5 | In |
Call | RIGL250919C00018000 | 13 | 18.0 | 2.35 - 5.4 | 3.92 | In |
Call | RIGL250919C00016000 | 10 | 16.0 | 4.0 - 7.0 | 4.3 | In |
Call | RIGL250919C00015000 | 4 | 15.0 | 4.7 - 7.6 | 5.0 | In |
Call | RIGL250919C00014000 | 2 | 14.0 | 5.7 - 8.5 | 5.7 | In |
Call | RIGL250919C00013000 | 8 | 13.0 | 6.3 - 9.5 | 8.0 | In |
Call | RIGL250919C00012000 | 1 | 12.0 | 7.3 - 8.9 | 9.4 | In |
Call | RIGL250919C00010000 | 6 | 10.0 | 9.1 - 12.5 | 11.7 | In |
Put | RIGL250919P00035000 | 0 | 35.0 | 14.3 - 17.3 | 14.3 | In |
Put | RIGL250919P00030000 | 0 | 30.0 | 9.2 - 12.5 | 9.2 | In |
Put | RIGL250919P00025000 | 1 | 25.0 | 4.9 - 7.8 | 6.6 | In |
Put | RIGL250919P00024000 | 0 | 24.0 | 4.0 - 7.0 | 4.0 | In |
Put | RIGL250919P00023000 | 0 | 23.0 | 3.2 - 6.5 | 3.2 | In |
Put | RIGL250919P00022000 | 0 | 22.0 | 2.0 - 5.5 | 2.0 | In |
Put | RIGL250919P00021000 | 0 | 21.0 | 1.6 - 5.0 | 1.6 | In |
Put | RIGL250919P00020000 | 6 | 20.0 | 0.75 - 4.8 | 3.0 | Out |
Put | RIGL250919P00019000 | 26 | 19.0 | 0.0 - 4.2 | 2.8 | Out |
Put | RIGL250919P00018000 | 18 | 18.0 | 0.0 - 3.3 | 1.95 | Out |
Put | RIGL250919P00017000 | 5 | 17.0 | 0.0 - 3.7 | 3.7 | Out |
Put | RIGL250919P00016000 | 2 | 16.0 | 0.0 - 3.4 | 1.66 | Out |
Put | RIGL250919P00015000 | 27 | 15.0 | 0.0 - 2.55 | 0.95 | Out |
Put | RIGL250919P00014000 | 1 | 14.0 | 0.0 - 4.4 | 0.65 | Out |
Put | RIGL250919P00013000 | 2 | 13.0 | 0.0 - 3.7 | 3.7 | Out |
Put | RIGL250919P00012000 | 1 | 12.0 | 0.0 - 4.1 | 0.35 | Out |
Put | RIGL250919P00009000 | 2 | 9.0 | 0.0 - 2.75 | 2.75 | Out |
Put | RIGL250919P00003000 | 2 | 3.0 | 0.0 - 2.75 | 2.75 | Out |
Rigel Total Stockholder Equity
Total Stockholder Equity |
|
Rigel Pharmaceuticals Corporate Management
| Raymond JD | General VP | Profile | |
| Tarek Sallam | Vice Marketing | Profile | |
| David Santos | Executive Officer | Profile | |
| Julie Patel | Senior Resources | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rigel Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 17.867 | Earnings Share 2.09 | Revenue Per Share | Quarterly Revenue Growth 0.806 | Return On Assets |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.